Selenoprotein V CRISPR/Cas9 KO Plasmid (h): sc-407114
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Selenoprotein V CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the Selenoprotein V genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Selenoprotein V CRISPR/Cas9 KO Plasmid (h) | sc-407114 | 20 µg | $397.00 |
Overview
SELENOV encodes selenoprotein V, a selenium-containing protein that incorporates selenocysteine and is linked to cellular redox homeostasis. Like other selenoproteins, it is associated with oxidative stress control and thiol-based redox processes that influence protein folding, signaling fidelity, and protection from reactive oxygen species. Altered selenoprotein biology and selenium utilization can impact pathways involved in inflammation and metabolic regulation, making SELENOV relevant for mechanistic studies of stress-adaptive responses. Its expression profile and predicted redox activity support investigation in contexts where oxidative balance and selenium-dependent protein networks contribute to disease-associated cellular phenotypes.
Selenoprotein V CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SELENOV gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SELENOV together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SELENOV open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Selenoprotein V protein expression.
This CRISPR knockout system enables efficient generation of SELENOV-deficient cell models for investigation of Selenoprotein V signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting SELENOV exon(s) critical for Selenoprotein V function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple SELENOV genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by Selenoprotein V CRISPR/Cas9 KO Plasmid (h) and Selenoprotein V CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the SELENOV locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by Selenoprotein V HDR Plasmid (h) and Selenoprotein V HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by SELENOV homology arms to support homology-directed repair at defined SELENOV target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.